Newsletter

Malaysia: MDA Regulatory Updates – Publication of First Edition Application for Confirmation Status of Obsolete and Discontinued Medical Device – March/April 2026

Malaysia: MDA Regulatory Updates – Publication of First Edition Application for Confirmation Status of Obsolete and Discontinued Medical Device – March/April 2026

  • 2026-04-28 08:14:56

The Medical Device Authority (MDA) has published the new guidance document, Application for Confirmation Status of Obsolete and Discontinued Medical Device (MDA/GD/0071). This publication was to assist establishments and healthcare professionals in understanding the applicable regulatory framework and in implementing appropriate control measures for obsolete and discontinued medical devices.

More
QT Activity: Webinar Recap | Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management – March/April 2026

QT Activity: Webinar Recap | Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management – March/April 2026

  • 2026-04-23 07:36:58

The webinar hosted by Qualtech in March takes a closer look at how medical device studies are conducted in the United States. Covering US FDA classification, IDE and IRB pathways, and study design, it connects regulatory frameworks with their practical application in study execution. This recap highlights key considerations shaping how studies are structured and managed in the US context.

More
Qualtech Webinar: Navigating Medical Device Studies in the US - Regulatory Strategy, Study Design, and Subject Management - March 2026

Qualtech Webinar: Navigating Medical Device Studies in the US - Regulatory Strategy, Study Design, and Subject Management - March 2026

  • 2026-03-04 08:36:52

Join Qualtech's free webinar, "Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management" on March 26, 2026. This complimentary session is designed to provide clear and practical insights into US regulatory expectations, study design considerations, and effective subject management strategies.

Take advantage of this opportunity to strengthen your understanding of US medical device study requirements

More
SINGAPORE: HSA IS RECOGNIZED BY WHO AS STRINGENT REGULATORY AUTHORITY (SRA) FOR CLASS C AND D IN VITRO DIAGNOSTIC MEDICAL DEVICES (IVD) - JULY/AUGUST 2023

SINGAPORE: HSA IS RECOGNIZED BY WHO AS STRINGENT REGULATORY AUTHORITY (SRA) FOR CLASS C AND D IN VITRO DIAGNOSTIC MEDICAL DEVICES (IVD) - JULY/AUGUST 2023

  • 2023-07-21 02:32:25

Singapore's Health Science Authority (HSA) is pleased to announce their status as a recognized Stringent Regulatory Authority (SRA) for Class C and D IVD by WHO. The SRA status means high-risk IVD products registered with HSA might obtain faster evaluation through WHO prequalification assessment, enabling manufacturers accelerated access to global markets.

More